Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q1 EPS of ($0.77), $0.23 better than the analyst estimate of ($1.00).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.